To view Dr. Shellock's CURRICULUM VITAE (pdf) that includes his publications pertaining to MRI safety, click here.

Frank G. Shellock, Ph.D. - Publications

 

Peer-Reviewed Articles

 

1. Shellock FG, Shah PK, Berman DS, Rubin SA, Singh BN, Swan HJC. Sustained benefits of oral pentaerythritol tetranitrate on ventricular, function in chronic congestive heart failure. Clinical Pharmacology and Therapeutics, 28:436-440, 1980.

 

2. Shah PK, Shellock FG, Berman DS, Rubin SA, Singh BN, Swan HJC. Sustained beneficial effects of oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure. Nouve Presse Medical, 9 (34 Suppl): 2447-2450, 1980.

 

3. Riedinger MS, Shellock FG, Swan HJC. Reading pulmonary artery and pulmonary capillary wedge pressure waveforms with respiratory variations. Heart and Lung, 10: 675-678, 1981.

 

4. Shellock FG, Rubin SA. Simplified and highly accurate core temperature measurements. Medical Progress Through Technology, 8: 187-188, 1982.

 

5. Nemerovski M, Shah PK, Berman DS, Shellock F, Swan HJC. Radio-nuclide assessment of sequential changes in left and right ventricular function following first transmural myocardial infarction. American Heart Journal, 104: 709-718, 1982.

 

6. Shellock FG, Rubin SA, Ellrodt AG, Muchlinski A, Brown H, Swan HJC. Unusual core temperature decrease in exercising heart failure patients. Journal of Applied Physiology, 54: 544-550, 1983.

 

7. Shellock FG, Riedinger MS. Reproducibility and accuracy of using room vs ice temperature injectate for thermodilution cardiac output determination. Heart and Lung, 12: 175-176, 1983.

 

8. Shah PK, Abdulla A, Pichler M, Shellock F, Berman D, Singh BN, Swan HJC. Effects of nitroprusside-induced reduction of elevated preload and afterload on global and regional ventricular function in acute myocardial infarction. American Heart Journal, 105: 531-542, 1983.

 

9. Shellock FG, Riedinger MS, Bateman TM, Gray RJ. Thermodilution cardiac output determination in hypothermic post-cardiac surgery patients: room vs ice temperature injectate. Critical Care Medicine, 11: 1108-1110, 1983.

 

10. Pichler M, Shah PK, Peter T, Singh B, Berman D, Shellock F, Swan HJC. Wall motion abnormalities and electrocardiographic changes in acute transmural myocardial infarction: implications of reciprocal ST segment depression. American Heart Journal, 106: 1003-1009, 1983.

 

11. Shellock FG. Physiological benefits of warm-up. Physician and Sports Medicine, 11: 134-142, 1983. Excerpted in 1984 Year Book of Sports Medicine.

 

12. Riedinger MS, Shellock FG. Technical aspects of the thermodilution method for measuring cardiac output. Heart and Lung, 13: 215-221, 1984.

 

13. Shellock FG, Rubin SA, Everest CE. Surface temperature measurement by IR. Medical Electronics, 84: 81-83, 1984.

 

14. Amin DK, Shah PK, Hulse S, Shellock FG, Swan HJC. Myocardial metabolic and hemodynamic effects of intravenous MDL 17,043, a new cardiotonic drug, in patients with chronic severe heart failure. American Heart Journal, 108: 1285-1292, 1984.

 

15. Shellock FG, Rubin SA. Temperature regulation during treadmill exercise in the rat. Journal of Applied Physiology, 57: 1872-1877, 1984.

 

16. Riedinger MS, Shellock FG, Shah PK, Weisfield A, Ellrodt AG. Sterility of prefilled thermodilution cardiac output injectate syringes maintained at ice and room temperature. Heart and Lung, 14: 8-11, 1985.

 

17. Amin DK, Shah PK, Shellock FG, Hulse S, Brandon G, Spangenberg R, Swan HJC. Comparative hemodynamic effects of intravenous dobutamine and MDL 17,043, a new cardioactive drug in severe congestive heart failure. American Heart Journal, 109: 91-98, 1985.

 

18. Shah PK, Amin DK, Hulse S, Shellock FG, Swan HJC. Inotropic therapy of refractory heart failure with oral fenoximone (MDL 17,043): Poor long-term results despite hemodynamic and clinical improvement. Circulation, 71: 326-331, 1985.

 

19. Amin DK, Shah PK, Hulse S, Shellock FG. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL 17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure. American Heart Journal, 109: 1006-1012, 1985.

 

20. Shellock FG, Rubin SA. Muscle and femoral vein temperatures during short-term maximal exercise in heart-failure. Journal of Applied Physiology, 58: 400-408, 1985. Excerpted in Year Book of Rehabilitation, 1986.

 

21. Shellock FG, Prentice WE. Warming-up and stretching for improvement of physical performance and prevention of sports-related injuries. Sports Medicine, 2: 267-278, 1985.

 

22. Shellock FG, Riedinger MS, Fishbein MC, Shah PK. Prevalence of brown adipose tissue in chronic congestive heart failure secondary to coronary artery disease. American Journal of Cardiology, 56: 197-198, 1985.

 

23. Shellock FG, Swan HJC, Rubin SA. Early central venous pressure changes in the rat during two different levels of head-down suspension. Aviation Space and Environmental Medicine, 56: 791-795, 1985.

 

24. Shellock FG, Rubin SA. Blood temperature response to exercise in heart-failure patients treated with short-term vasodilators. Clinical Physiology, 5:503-514, 1985.

 

25. Shellock FG. Muscoli caldi per vincere (Warming-up for competition) Sport & Medicina, (Italy) 3: 27-31, 1986.

 

26. Shellock FG, Riedinger MS, Fishbein MC. Brown adipose tissue in cancer-induced cachexia. Journal of Cancer Research and Clinical Oncology, 111: 82-85, 1986.

 

27. Shellock FG. Physiological, psychological, and injury prevention aspects of warm-up. National Strength and Conditioning Association Journal, 8: 24-27, 1986.

 

28. Shellock FG, Schaefer DJ, Gordon CJ. Effect of a 1.5 Tesla static magnetic field on body temperature of man. Magnetic Resonance in Medicine, 3: 644-647, 1986.

 

29. Shellock FG, Gordon CJ, Schaefer DJ. Thermoregulatory responses to clinical magnetic resonance imaging of the head at 1.5 Tesla: Lack of evidence for direct effects on the hypothalamus. Acta Radiologica, Suppl. 369: 512-513, 1986.

 

30. Shellock FG, Schaefer DJ, Grundfest W, Crues JV. Thermal effects of high-field (1.5 Tesla) magnetic resonance imaging of the spine: Clinical experience above a specific absorption rate of 0.4 W/kg. Acta Radiologica, Suppl. 369: 514-516, 1986.

 

31. Shellock FG. Seguiamo il destino dell acido lattico (The post-exercise path of lactic acid). Sport & Medicina (Italy). 4: 27-30, l987.

 

32. Shellock FG, Crues JV. Temperature, heart rate, and blood pressure changes associated with clinical magnetic resonance imaging at 1.5 T. Radiology, 163: 259-262, 1987.

 

33. Shellock FG, Crues JV. MRI: Potential adverse effects and safety considerations. MRI Decisions, 2:25-30, 1988.

 

34. Shellock FG, Crues JV. Temperature changes caused by clinical MR imaging of the brain at

1.5 Tesla using a head coil. American Journal of Neuroradiology, 9: 287-291, 1988.

 

35. Shellock FG, Crues JV. Corneal temperature changes associated with high-field MR imaging
            of the brain with a head coil. Radiology, 167: 809-811, 1988.

 

36. Shellock FG, Mink JH, Fox JM. Patellofemoral joint: Kinematic MR imaging to assess

tracking abnormalities. Radiology, 168:551-553, 1988.

 

37. Shellock FG, Crues JV. High-field MR imaging of metallic biomedical implants: An ex vivo evaluation of deflection forces. American Journal of Roentgenology. 151: 389-392, 1988.

 

38. Shellock FG. MR imaging of metallic implants and materials: A compilation of the literature.
            American Journal of Roentgenology. 151: 811-814, 1988.

 

39. Pressman BD, Shellock FG. Static and kinematic magnetic resonance   imaging of bilateral

            temporomandibular joints using dual surface coils. Journal of the California Dental

            Association. August, pp 32-36, 1988. Excerpted in Oral Health, August 1989, Canada.

 

40. Shellock FG, Schaefer DJ, Crues JV. Exposure to a 1.5 Tesla static magnetic field does not

            alter body and skin temperatures in man. Magnetic Resonance in Medicine, 11:371-375,

            1989.

 

41. Shellock FG, Pressman BD. Dual-surface-coil MR imaging of bilateral temporomandibular

            joint: Improvements in the imaging protocol. American Journal of Neuroradiology,

            10:595-598, 1989.

 

42. Shellock FG, Mink JH, Deutsch A, Fox JM. Kinematic magnetic resonance imaging for

            evaluation of patellar tracking: A case report. The Physician and Sports Medicine, 17:99-

            108, 1989.

 

43. Shellock FG, Mink JH, Deutsch A, Fox JM. Patellar tracking abnormalities: Clinical

            experience with kinematic MR imaging in 130 patients. Radiology, 172:799-804, 1989.

            Excerpted in Advances in Orthopedic Surgery, 1990.

 

44. Shellock FG. Biological effects and safety aspects of magnetic resonance imaging. Magnetic

            Resonance Quarterly 5:243-261, 1989.

 

45. Shellock FG, Schaefer DJ, Crues JV. Alterations in body and skin temperatures caused by

            MR imaging: Is the recommended exposure for radiofrequency radiation too

            conservative? British Journal of Radiology, 62:904-909, 1989.

 

46. Hong CZ, Shellock FG. Short-term exposure to a 1.5 Tesla static magnetic field does not

            effect somato-sensory evoked potentials in man. Magnetic Resonance Imaging. 8:65-69,

            1990.

 

47. Shellock FG, Slimp G. Halo vest for cervical spine fixation during MR imaging. American

            Journal of Roentgenology, 154:631-632, 1990.

 

48. Deutsch AL, Mink JH, Shellock FG. Magnetic resonance imaging of injuries to bone and

            articular cartilage: Emphasis on radiographically occult abnormalities. Orthopedic

            Reviews, 19:66-75, 1990.

 

49. Shellock FG, Rothman B, Sarti D. Heating of the scrotum by high-field-strength MR imaging.

            American Journal of Roentgenology 154:1229-1232, 1990.

 

50. Kanal E, Shellock FG, Talagala L. Safety considerations in MR imaging. Radiology, 176:593-

            606, 1990.

 

51. Shellock FG, Mink JH, Deutsch A, Fox JM, Ferkel RD. Evaluation of patients with persistent

            symptoms following lateral retinacular release by kinematic MRI of the patellofemoral

            joint. Arthroscopy, 6:226-234, 1990.

 

52. Shellock FG, Kanal E. Policies, guidelines, and recommendations for MR imaging safety

            and patient management. Journal of Magnetic Resonance Imaging, 1:97-101, 1991.

 

53. Shellock FG, Schatz CJ. High field strength MRI and otologic implants. American Journal of

            Neuroradiology, 12:279-281, 1991.

 

54. Shellock FG, Fukunaga T, Mink JH, Edgerton VR. Acute effects of exercise on MRI of

            skeletal muscle: Concentric vs. eccentric actions. American Journal of Roentgenology,

            156:765-768, 1991.

 

55. Conway WF, Hayes CW, Loughran T, Totty WG, Griffeth LK, El-Khoury GY, Shellock FG.

            Cross-sectional imaging of the patellofemoral joint and surrounding structures.

            RadioGraphics, 11:195-211, 1991.

 

56. Shellock FG, Mink JH, Fox JM. Identification of medial subluxation of the patella in a dancer

            using kinematic MRI of the patellofemoral joint: a case report. Kinesiology and Medicine

for Dance 13:1-9, 1991.

 

57. Shellock FG, Mink JH. Knees of trained long-distance runners: MR imaging before and after

            competition. Radiology, 179:635-637, 1991.

 

58. Shellock FG, Mink JH, Deutsch A, Pressman B. Kinematic MRI of the joints: techniques and
            clinical applications. Magnetic Resonance Quarterly, 7:104-135, 1991.

 

59. Shellock FG, Fukunaga T, Mink JH, Edgerton VR. Exertional muscle injury: Evaluation of

            concentric vs eccentric actions with serial MR imaging. Radiology, 179:659-664, 1991.

 

60. Hong CZ, Shellock FG. Effects of a topically applied counterirritant (Eucalyptamint) on

            cutaneous blood flow and on skin and muscle temperatures. American Journal of

            Medicine and Rehabilitation, 70:29-33, 1991.

 

61. Shellock FG. Patellofemoral joint abnormalities in athletes: Evaluation by kinematic MRI.

            Topics in Magnetic Resonance Imaging, 3:1-30, 1991.

 

62. Fleckenstein J, Shellock FG. Exertional muscle injury: MRI evaluation. Topics in Magnetic

            Resonance Imaging, 3:31-55, 1991

 

63. Shellock FG, Foo TKF, Deutsch A, Mink JH. Patellofemoral joint: Evaluation during active

            flexion with ultrafast spoiled GRASS MR imaging. Radiology, 180:581-585, 1991.

 

64. Shellock FG, Curtis JS. MR imaging and biomedical implants, materials, and devices: An

            updated review. Radiology, 180:541-550, 1991.

 

65. Yuh WTC, Hanigan MT, Nerad JA, Carter KD, Kardon RH, Ehrhardt JC, Shellock FG.

            Extrusion of a magnetic eye implant after MR examination: A potential hazard to the

            enucleated eye. Journal of Magnetic Resonance Imaging. 1:711-713, 1991.

 

66. Shellock FG, Deutsch A, Mink JH, Kerr R. Do asymptomatic marathon runners have an

            increased prevalence of meniscal abnormalities? An MR study of the knee in 23

            volunteers. American Journal of Roentgenology, 157:1239-1241, 1991.

 

67. Shellock FG, Schatz CJ, Julien P, Steinberg F, Foo TKF, Hopp ML, Westbrook PR. Dynamic

            study of the upper airway using ultrafast spoiled GRASS MR imaging. Journal of

            Magnetic Resonance Imaging.2:103-107, 1992.

 

68. Shellock FG, Morris E, Deutsch AL, Mink JH, Kerr R, Boden SD. Hematopoietic bone

            marrow hyperplasia: High prevalence on MR images of the knee in asymptomatic

            marathon runners. American Journal of Roentgenology, 158: 335-338, 1992.

 

69. Shellock FG, Myers SM, Kimble K. Monitoring heart rate and oxygen saturation during MRI

with a fiber-optic pulse oximeter. American Journal of Roentgenology, 158: 663-664,

1992.

 

70. Yuh WTC, Ehrhardt JC, Fisher DJ, Shields RK, Shellock FG. Phantom limb pain induced in

amputee by strong magnetic fields. Journal of Magnetic Resonance Imaging, 2: 221-223,

1992.

 

71. Shellock FG, Schatz CJ, Julien P, Silverman JM, Steinberg F, Foo TKF, Hopp ML,

Westbrook PR. Occlusion and narrowing of the pharyngeal airway in obstructive sleep

apnea: evaluation by ultrafast spoiled GRASS MR imaging. American Journal of Roentgenology, 158: 1019-1024, 1992.

 

72. Foo TF, Shellock FG, Hayes CE, Schenck JF, Slayman BE. High resolution MR imaging of

            the wrist and eye using short TE, short TR, and partial echo acquisition. Radiology, 183:

            277-281, 1992.

 

73. Shellock FG, Mink JH, Curtin S, Friedman MJ. MRI and orthopedic implants used for
            anterior cruciate ligament reconstruction: Assessment of ferromagnetism and artifacts.
            Journal of Magnetic Resonance Imaging, 2: 225-228, 1992.

 

74. Kanal E, Shellock FG. Policies, guidelines, and recommendations for MR imaging safety and

patient management. Patient monitoring during MR examinations. Journal of Magnetic

Resonance Imaging, 2: 247-248, 1992.

 

75. Shellock FG, Litwer C, Kanal E. MRI bioeffects, safety, and patient management: a review.

Reviews in Magnetic Resonance Imaging, 4:21-63, 1992.

 

76. Pressman BD, Shellock FG, Schames J, Schames M. MRI evaluation of TMJ abnormalities

             associated with cervical hyperextension/hyperflexion (whiplash) injuries. Journal of
            Magnetic Resonance Imaging, 2: 569-574, 1992.

 

77. Shellock FG, Mink JH, Deutsch AL, Foo TKF. Kinematic MR imaging of the patellofemoral
            joint: Comparison between passive positioning and active movement techniques.
            Radiology, 184:574-577, 1992.

 

78. McCully K, Shellock FG, Bank W, Posner J. The use of nuclear magnetic resonance to
            evaluate muscle injury. Medicine and Science in Sports and Exercise, 24:537-542, 1992.

 

79. Kanal E, Shellock FG. Patient monitoring during clinical MR imaging. Radiology, 185: 623-
            629, 1992.

 

80. Shellock FG, Schatz CJ. Increases in corneal temperature caused by MR imaging of the eye
            with a dedicated local coil. Radiology, 185: 697-699, 1992.

 

81. Fukunaga T, Roy RR, Shellock FG, Hodgson JA, Day MK, Lee PL, Kwong-Fu H, Edgerton
            VR. Physiological cross-sectional area of human leg muscles based on magnetic
            resonance imaging. Journal of Orthopaedic Research, 10: 926-934, 1992.

 

82. Sinha S, Gorczyca D, Debruhl ND, Shellock FG, Gausche V, Bassett LW. MR imaging of
            silicone breast implants: comparison of different coil arrays. Radiology, 187:284-286,
            1993.

 

83. Kanal E, Gillen J, Evans JA, Savitz DA, Shellock FG. Survey of reproductive health among
            female MR operators. Radiology 187:395-399, 1993.

 

84. Kanal E, Shellock FG. MR imaging of patients with intracranial aneurysm clips. Radiology,
            187: 612-614, 1993.

 

85. Holshouser B, Hinshaw DB, Shellock FG. Sedation, anesthesia, and physiologic monitoring
            during MRI. Journal of Magnetic Resonance Imaging, 3: 553-558, 1993.

 

86. Shellock FG, Mink JH, Deutsch AL, Foo TKF, Sullenberger P. Patellofemoral joint:
            identification of abnormalities using active   movement, "unloaded" vs "loaded" kinematic
            MR imaging techniques. Radiology, 188:575-578, 1993.


 


87. Shellock FG, Hahn HP, Mink JH, Itskovich E. Adverse reaction to IV gadoteridol. Radiology,
            189:151-152, 1993.

 

88. Shellock FG, Morisoli S, Kanal E. MR procedures and biomedical implants, materials, and
            devices: Update 1993. Radiology, 189:587-599, 1993.

 

89. Farahani K, Lufkin RB, Shellock FG, Hirshowitz S, Castro DJ, Lufkin RB. Chronic effects in
            temperature-controlled application of MRI-monitored interstitual laser therapy. SPIE
            1882:195-101, 1993.

 

90. Kanal E, Shellock FG. The value of published data on MR compatibility of metallic implants.
            American Journal of Neuroradiology, 15:1394-1396, 1994.

 

91. Shellock FG, Kanal E. SMRI Report. Policies, guidelines and recommendations for MR
            imaging safety and patient management.  Questionnaire for screening patients before MR
            procedures. Journal of Magnetic Resonance Imaging. 4:749-751, 1994.

Magnetic Resonance Safety Testing Services

Publications

© 2026 Magnetic Resonance Safety Testing Services, Inc.  All rights reserved.